Market Indices


Latest News

NexImmune, Inc. (NEXI) - This analysis reviews how the stock price...

April 2, 2025   NEXI 0.00%

Biora Therapeutics, Inc. (BIOR) - This analysis reviews how the stock...

April 2, 2025   BIOR 0.00%

Panbela Therapeutics, Inc. (PBLA) - This analysis reviews how the stock...

April 2, 2025   PBLA -0.09%

Qualigen Therapeutics, Inc. (QLGN) - This analysis reviews how the stock...

April 2, 2025   QLGN -2.29%

ToughBuilt Industries, Inc. (TBLT) - This analysis reviews how the stock...

April 2, 2025   TBLT -14.63%


Price Targets

from Leerink Partners issued a price target of $20.00 for TENX on 2025-03-10 10:22:00.The adjusted price target was set to $20.00.At the time of the announcement, TENX...

March 10, 2025   TENX -0.94%

Matthew Caufield from H.C. Wainwright issued a price target of $32.00 for SRZN on 2025-01-30 11:04:21.The adjusted price target was set to $32.00.At the time of the announcement,

January 30, 2025   SRZN 6.65%

Scott Buck from H.C. Wainwright issued a price target of $1.50 for WKSP on 2025-01-23 11:03:23.The adjusted price target was set to $1.50.At the time of the announcement,

January 23, 2025   WKSP 1.22%

Yatin Suneja from Guggenheim issued a price target of $45.00 for SRZN on 2025-01-03 11:15:22.The adjusted price target was set to $45.00.At the time of the announcement, SRZN...

January 3, 2025   SRZN 6.65%

Biren Amin from Piper Sandler issued a price target of $35.00 for CRBP on 2024-12-02 09:09:00.The adjusted price target was set to $35.00.At the time of the announcement,

December 2, 2024   CRBP 3.38%



Market Movers

Top Gainers (%)
APVO
Aptevo Therapeutics Inc.
1.38
38.26%
QNRX
Quoin Pharmaceuticals, Lt
0.29
38.23%
CRVO
CervoMed Inc.
13.58
36.07%
XELA
Exela Technologies, Inc.
0.60
30.43%
TCRT
Alaunos Therapeutics, Inc
2.80
29.63%
TIVC
Tivic Health Systems, Inc
3.25
28.97%
BDRX
Biodexa Pharmaceuticals P
1.54
28.33%
GNPX
Genprex, Inc.
0.30
28.21%

Annual/Quarterly Reports Summary

In a landscape of fluctuating revenues and complex operating expenses, KKR navigates its financial journey with strategic investments and a commitment to transparency. Management emphasizes the importance of timely decision-making...

November 5, 2024   KKRS 0.34%

In the latest quarter, the company reported a revenue of 96, marking a 33 increase, while operating expenses rose slightly to 2,776. Despite these fluctuations, net income reached 1,096, reflecting...

November 5, 2024   CTBB -1.48%